ACC: 1999 to 2022 Saw Increase in Maternal Mortality Due to CVD
By Elana Gotkine HealthDay Reporter
WEDNESDAY, April 2, 2025 -- From 1999 to 2022, there was a considerable increase in maternal mortality due to cardiovascular disease (CVD), according to a study presented at the annual meeting of the American College of Cardiology, held from March 29 to 31 in Chicago.
Mohammad Ahabab Hossain, M.D., from Rutgers New Jersey Medical School in Newark, and colleagues queried the CDC-WONDER database to identify women of reproductive age (15 to 44 years) who experienced maternal mortality from CVD from 1999 to 2022. Age-adjusted mortality rates (AAMRs) were calculated per 1 million individuals and were stratified by year, race, and U.S. census region.
The researchers found 7,581 maternal deaths from CVD among the study population during the 22-year period. From 1999 to 2022, there was an increase in AAMR from CVD-related mortality, from 3.62 to 9.08 among all women aged 15 to 44 years, with a peak of 10.52 in 2021. From 2018 to 2022, the highest AAMR was seen in Black women versus White women (21.91 versus 7.10) and in the South versus the West (12.14 versus 5.41).
"The United States is supposed to be a global leader in advancing health and medicine, and the fact that we still have pregnant women who are dying -- often because of preventable causes -- should sound alarm bells," Hossain said in a statement. "The fact that there are disparities based on race means we need to pay better attention to more vulnerable populations, specifically Black women."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
Seniors With RSV-Linked Hospitalization Have Increased Cardiovascular Outcomes
THURSDAY, July 24, 2025 -- In older adults, respiratory syncytial virus (RSV) is associated with an increased risk for cardiovascular outcome, especially heart failure events...
USPSTF Guidelines of Little Value for Estimating Preeclampsia Risk in Those at Moderate Risk
WEDNESDAY, July 23, 2025 -- Moderate U.S. Preventive Services Task Force (USPSTF) preeclampsia risk factors have little value for estimating the risk for preeclampsia, according...
Specific Antiseizure Medications Associated With Major Malformations in Infants
FRIDAY, July 18, 2025 -- Maternal use of valproate, phenobarbital, and topiramate early in pregnancy is associated with an increased risk for major malformations in infants...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.